NSU Researcher Explores New Approaches to Alzheimer’s Disease

Dr. Mohammad Golam Sabbir, an assistant professor in Nova Southeastern University’s Department of Psychology and Neuroscience, is working to uncover new ways to slow the progression of Alzheimer’s disease.
With support from Miami-based biotech company Curallux, LLC, he is studying how brain cells lose the ability to communicate as the disease advances and exploring therapies that could protect memory and cognitive function. Alzheimer’s disease affects millions of Americans, gradually eroding memory, thinking, and independence.
Dr. Sabbir’s research focuses on a key brain receptor involved in memory, which is often lost early in the disease. His findings suggest that treatments aimed only at boosting brain chemicals may not be an effective therapeutic strategy for many patients, pointing to the need for new strategies that restore the brain’s natural signaling pathways. One promising approach Dr. Sabbir is investigating is photobiomodulation, a non-invasive therapy using low-level red or near-infrared light to stimulate biological processes in cells and tissues.
By combining this with strategies to restore critical brain receptors, his work aims to protect neurons, slow cognitive decline, and bring the field closer to more effective treatments for Alzheimer’s patients.
Explore Dr. Sabbir’s research publications here.